GNNSF Estados financieros: Análisis de Genscript Biotech Corporation AI

Inicio

Acciones

GNNSF

GNNSF Financiero

Genscript Biotech Corporation

$1.55

-12.42%

$-0.21

Al cierre: Feb 13, 16:00:00 GMT-5

$1.55

Mercado Posterior: Feb 13, 20:00:00 GMT-5

Visión general Pronóstico Ganando Dividendos Finanzas

Ingreso

Balance general

Flujo de efectivo

Anual

Trimestral

GNNSF Ingreso

Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Ingresos	551	594	560	625	490	390
Crecimiento de los Ingresos (YoY)	21%	6%	-10%	28%	26%	43%
Costo de los ingresos	266	322	289	321	207	134
Utilidad bruta	285	272	270	304	282	255
Venta, General y Administración	97	209	191	351	303	197
Investigación y Desarrollo	-151	53	52	390	358	263
Gastos de Operación	-51	380	109	735	804	462
Otras Ingresos (Gastos) No Operativos	-8	-4	-3	-1	0	-4
Ingreso antes de impuestos	34	-170	168	-431	-517	-281
Gasto por Impuesto a la Renta	17	2	6	-3	0	0
Ingreso Neto	3,111	2,961	-95	-226	-358	-204
Crecimiento de la Utilidad Neta	-1,857.99%	-3,217%	-57.99%	-37%	75%	112.99%
Acciones en Circulación (Diluidas)	2,154.85	2,121.28	2,109.36	2,104.12	2,039.2	1,900.78
Cambio de Acciones (YoY)	2%	1%	0%	3%	7%	2%
EPS (Diluido)	1.44	1.39	-0.04	-0.1	-0.17	-0.1
Crecimiento de EPS	-1,900%	-3,575%	-63%	-39%	63%	107%
Flujo de efectivo libre	141	-72	-444	-323	-274	-278
Flujo de efectivo libre por acción	--	--	--	--	--	--
Margen bruto	51.72%	45.79%	48.21%	48.64%	57.55%	65.38%
Margen de operación	60.98%	-18.18%	28.57%	-68.96%	-106.53%	-52.82%
Margen de beneficio	564.6%	498.48%	-16.96%	-36.16%	-73.06%	-52.3%
Margen de flujo de caja libre	25.58%	-12.12%	-79.28%	-51.68%	-55.91%	-71.28%
EBITDA	408	-31	233	-367	-475	-174
Margen de EBITDA	74.04%	-5.21%	41.6%	-58.72%	-96.93%	-44.61%
D&A para EBITDA	72	77	73	64	47	32
EBIT	336	-108	160	-431	-522	-206
Margen de EBIT	60.98%	-18.18%	28.57%	-68.96%	-106.53%	-52.82%
Tasa de Impuesto Efectiva	50%	-1.17%	3.57%	0.69%	0%	0%

Estadísticas clave

Cierre Anterior

$1.77

Precio de apertura

$1.55

Rango del día

$1.55 - $1.55

Rango de 52 semanas

$1.24 - $2.42

Volumen

3.6K

Volumen promedio

513

EPS (TTM)

-0.04

Rendimiento de dividendos

Cap. de mercado

$3.3B

¿Qué es Genscript Biotech Corp?

Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. The company is headquartered in Nanjing, Jiangsu and currently employs 5,769 full-time employees. The company went IPO on 2015-12-30. The firm operates its businesses through five segments. The Life-science Services and Products segment provides comprehensive research services and products. The Biologics Development Services segment provides comprehensive services to help biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene, cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment provides industrial enzyme development and production through non-pathogenic microbial strains constructed using genetic engineering. The Cell Therapy segment discovers and develops CAR-T therapies for the treatment of liquid and solid tumors. The Operation segment provides shared services to other segments. The firm mainly operates its businesses in the domestic and overseas markets.



Características

Copiloto de IA para Acciones y Criptomonedas

Predicción de precios

Seguimiento de Recaudación de Fondos

Temas

Comparación de Criptomonedas

Recursos